EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries
about
Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptorsGlial and neuronal control of brain blood flowProstaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors.Endothelial dysfunction and decreased vascular responsiveness in the anterior cruciate ligament-deficient model of osteoarthritis.Prostanoid receptor antagonists: development strategies and therapeutic applicationsEmerging roles of PGE2 receptors in models of neurological disease.Distinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulationA ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.Differential reactivity of human mammary artery and saphenous vein to prostaglandin E(2) : implication for cardiovascular grafts.A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophyThe pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache.Signaling via the prostaglandin E₂ receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia.Potassium channels and neurovascular coupling.Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials.Contribution of prostanoid signaling to the evolution of spreading depolarization and the associated cerebral blood flow response.Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tonePerivascular nerves and the regulation of cerebrovascular tone.Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice.Neurovascular coupling in humans: Physiology, methodological advances and clinical implications.Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2.Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.Astrocyte regulation of cerebral vascular tone.BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.The complex contribution of NOS interneurons in the physiology of cerebrovascular regulation.COX inhibitors for the treatment of migraine.Hypoxemia, oxygen content, and the regulation of cerebral blood flowMechanisms Mediating Functional Hyperemia in the Brain.Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: possible role of tissue inhibitor of metalloproteinase-3GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels.Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine.Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.Ca(2+) signals evoked by histamine H1 receptors are attenuated by activation of prostaglandin EP2 and EP4 receptors in human aortic smooth muscle cells.Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs.Prostaglandin E2(PGE2) induces headache in healthy subjects.Prostaglandins mediate tonic contraction of the guinea pig and human gallbladder.Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension.Diverse effects of prostaglandin E₂ on vascular contractility.Carbon dioxide-mediated vasomotion of extra-cranial cerebral arteries in humans: a role for prostaglandins?
P2860
Q28569384-F091A268-1D38-4738-899D-37426C145683Q29620058-05573AC1-426B-414E-90FD-7DA5B14A2DB6Q33262176-0F4A360C-E2C8-4915-9D3F-582CF7AA274EQ33262584-953B833B-6A24-4756-9760-9EB0196931A4Q33485483-0E0C1BDB-61F7-4150-A6B5-DED91D961EE2Q33756150-BD185BE8-8C1E-493C-8443-F10922904E06Q34281269-318A16EB-6835-45F4-9713-C26418B8E1B9Q34520481-A23059D1-C47D-4F84-AC7E-47C6A1E2E25EQ34954633-E2B6F476-305A-4267-B449-1214D31894EEQ35036193-9E557F14-48B0-452F-B072-F9C21018270EQ35085903-4CE4F295-2786-4BF3-B548-E837E1DEC3BCQ35214562-0BD94F40-157E-4ED5-8171-836BAAC6F0F6Q35484819-3AE49782-037C-4B60-BD4C-89E5E90659F6Q35510178-540C337D-B668-48F9-A2C5-A45888A2E517Q35832190-60C507DD-40F4-446C-910E-669608EB7F40Q36099329-197DD090-37B7-4C08-9A9A-0871B0780F3BQ36118847-DE45F1B4-0412-4D87-8487-5DFA1C5AD501Q36391631-66426010-BCEF-49CD-AB29-338888A6B2D2Q36535634-005BF6B1-9404-406E-814D-28E219669006Q36765857-C84BC090-93E9-4CE9-8C5F-87B1E95198C6Q36796418-016A4730-D527-4284-A64E-6AE865F3E023Q36842517-104369F8-C850-477A-87F6-1F5BE10B0A92Q37142749-A97223AB-1124-461F-88DF-D44F53E42ED8Q37230998-65525E91-6CBF-4C89-A174-2B345F923297Q38036205-807F4DAE-2CDA-462B-895D-15F32F0A0C66Q38227997-7AF702BD-0A3D-4738-86DB-9A92D4B129DFQ38671519-B3BF63D0-C371-4C05-B1A1-306154A3D5A6Q39238290-BEE50376-ADFD-419B-A199-AD55DC54500BQ39257639-F3AE4EE2-72F2-4EAE-B4BF-95935B299E6DQ40294227-4D9C49A2-737F-491D-9094-E52C815482C6Q42935835-C6EB78CF-B6F3-4E74-9939-27FC5514964AQ42936119-CD87FA6C-A58D-4047-9B41-337E779F84C7Q42940476-D0D91F84-1CD4-40C5-8ED2-87B261B20510Q43073261-2379A988-A2DD-4BB0-BCC1-53AF9635B749Q45926654-830E6629-AC1B-41A7-9FBA-F4EB8488065CQ46136517-95C9771A-92C4-4D4F-9553-95687BF3D28DQ46267351-92919CBC-120A-43B2-B5CD-31B847605907Q46604316-6BB19697-8723-44AA-AC2B-4AE1D8C36C3BQ46649673-9162C05E-310D-4980-9C7F-D5B2C7EF26D6Q48237898-0126B1B7-5DE0-45E2-8B58-274198184D44
P2860
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries
@en
type
label
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries
@en
prefLabel
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries
@en
P2093
P2860
P356
P1476
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries
@en
P2093
Gordon S Baxter
Kenneth L Clark
Nick Tilford
Richard J Davis
Rivka Ravid
Robert A Coleman
Robert L G Sheldrick
Stuart Purbrick
P2860
P304
P356
10.1038/SJ.BJP.0705645
P407
P577
2004-01-26T00:00:00Z